Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Paul Makhzoum

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
European Journal of Rheumatology|February 14, 2022
Updates in ANCA-associated vasculitisCarolyn Ross, Jean-Paul Makhzoum, Christian Pagnoux
Case Reports in Nephrology|May 31, 2021
A Case of Severe and Refractory Membranous Nephropathy Associated to Mucous Membrane PemphigoidEric Mereniuk, Laura Sabbah, Jean-Paul Makhzoum
International Journal of Rheumatology|March 10, 2020
A Review of Primary Vasculitis Mimickers Based on the Chapel Hill Consensus ClassificationFarah Zarka, Charles Veillette, Jean-Paul Makhzoum
Rheumatology and Therapy|December 24, 2025
Treatment Patterns and Clinical Outcomes for Patients Living with Active Giant Cell Arteritis in CanadaJean-Paul Makhzoum, Miriam Avadisian, Dalinda Liazoghli
Journal of the American Academy of Dermatology|March 29, 2025
Current therapeutic options for adult patients with urticarial vasculitis: A scoping reviewAnne-Sophie Groleau, Alexandra Mereniuk, Jean-Paul Makhzoum
The American Journal of Case Reports|October 14, 2022
Rare Ischemic Complications of Giant Cell Arteritis: Case Series and Literature ReviewDarya S Jalaledin, Carolyn Ross, Jean-Paul Makhzoum
International Journal of Rheumatology|April 30, 2021
Update in the Management of ANCA-Associated Vasculitis: Recent Developments and Future PerspectivesKarla N Samman, Carolyn Ross, Christian Pagnoux, et al.
Rheumatology Advances in Practice|December 1, 2025
The effectiveness and safety of leflunomide in the treatment of giant cell arteritis: a systematic review and meta-analysisLinda M Zhu, Arielle Mendel, Carolyn Ross, et al.
Therapeutic Advances in Musculoskeletal Disease|March 2, 2026
Risk factors for acute coronary syndrome in patients with giant cell arteritis: a scoping reviewEugénie Pelletier, Caitlyn Kanters, Stéphanie Ducharme-Bénard, et al.
Seminars in Arthritis and Rheumatism|December 28, 2025
Management of antineutrophil cytoplasmic antibody vasculitis-associated orbital inflammatory disease: A systematic literature reviewEmma Neary, Katie Healey, Marie Clements-Baker, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
European Journal of Rheumatology|February 14, 2022
Updates in ANCA-associated vasculitisCarolyn Ross, Jean-Paul Makhzoum, Christian Pagnoux
Case Reports in Nephrology|May 31, 2021
A Case of Severe and Refractory Membranous Nephropathy Associated to Mucous Membrane PemphigoidEric Mereniuk, Laura Sabbah, Jean-Paul Makhzoum
International Journal of Rheumatology|March 10, 2020
A Review of Primary Vasculitis Mimickers Based on the Chapel Hill Consensus ClassificationFarah Zarka, Charles Veillette, Jean-Paul Makhzoum
Rheumatology and Therapy|December 24, 2025
Treatment Patterns and Clinical Outcomes for Patients Living with Active Giant Cell Arteritis in CanadaJean-Paul Makhzoum, Miriam Avadisian, Dalinda Liazoghli
Journal of the American Academy of Dermatology|March 29, 2025
Current therapeutic options for adult patients with urticarial vasculitis: A scoping reviewAnne-Sophie Groleau, Alexandra Mereniuk, Jean-Paul Makhzoum
The American Journal of Case Reports|October 14, 2022
Rare Ischemic Complications of Giant Cell Arteritis: Case Series and Literature ReviewDarya S Jalaledin, Carolyn Ross, Jean-Paul Makhzoum
International Journal of Rheumatology|April 30, 2021
Update in the Management of ANCA-Associated Vasculitis: Recent Developments and Future PerspectivesKarla N Samman, Carolyn Ross, Christian Pagnoux, et al.
Rheumatology Advances in Practice|December 1, 2025
The effectiveness and safety of leflunomide in the treatment of giant cell arteritis: a systematic review and meta-analysisLinda M Zhu, Arielle Mendel, Carolyn Ross, et al.
Therapeutic Advances in Musculoskeletal Disease|March 2, 2026
Risk factors for acute coronary syndrome in patients with giant cell arteritis: a scoping reviewEugénie Pelletier, Caitlyn Kanters, Stéphanie Ducharme-Bénard, et al.
Seminars in Arthritis and Rheumatism|December 28, 2025
Management of antineutrophil cytoplasmic antibody vasculitis-associated orbital inflammatory disease: A systematic literature reviewEmma Neary, Katie Healey, Marie Clements-Baker, et al.
Pageof 4